Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Sigilon

<< Previous

Bullboard Posts

Next >>

Comment by Metalsguy1on Mar 25, 2021 8:09pm

190 Views

Post# 32883596

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Sigilon

Thus Biotecks rose tinted glasses context. The market is people and if you hadn't noticed from comments on this board, there are quite a number of shareholders here that directly or indirectly hold extremely large positions, some in the 10 to 20 million share range who would pack up and move on in the face of a RS. What you fail to grasp is that all of this lolling about means the overall rate of return drops the longer we spend in these protracted consolidations. I am not saying Sernova won't get there but their peers in the sector seem to be much more sophisticated,

<< Previous

Bullboard Posts

Next >>

Mastering options Greeks: Essential knowledge for informed trading